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Abstract
Background: Following the repair of TOF patients may be left with pulmonary
regurgitation and a dilated right ventricle (RV), which in turn can lead to ventricular
arrhythmias and sudden death. A prolonged QRS is a predictor of ventricular ar-
rhythmias. However, whether subsequent pulmonary valve replacement (PVR) can
reverse QRS‐prolongation is controversial. We hypothesized that changes in QRS
duration following PVR are determined by preoperative QRS‐duration and RV
volumes
Methods: A retrospective single‐center cohort study was conducted on 142 post‐
TOF repair patients (mean age 25 ± 13 years) who underwent PVR between 1995
and 2019. Information on QRS duration and RV volumes measured by cardiac MRI
(available in 83 patients) were collected. A linear mixed model was used to
investigate the association between the preoperative QRS duration and RV volumes
and the postoperative QRS duration.
Results: The QRS‐duration following PVR continued to increase in all subjects with a
prolonged preoperative QRS‐duration(>160ms, rate of increase of 0.87msec ± 0.33
per year; p = .01), markedly raised RV end‐diastolic volume (RVEDV; ≥166ml/m2, rate
of increase of 2.0msec ± 0.37 per year; p < .01) or RV end‐systolic volume (RVESV;
≥89ml/m2, rate of increase of 1.25msec ± 0.43 per year; p = .01). In contrast, in pa-
tients with preoperative QRS‐duration <160msec (p = .16), RVEDV <166ml/m2
(p = .14), or RVESV < 89ml/m2 (p = .37), the QRS‐duration did not change significantly
when compared to preoperative values.
Conclusions: In subjects with shorter QRS and smaller RV volumes, QRS duration
did not show further prolongation following PVR. While markedly prolonged QRS
and increased RV volumes were associated with a small but constant increase in
QRS duration despite PVR.
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1 | INTRODUCTION
Surgical repair of tetralogy of Fallot (TOF) in children is associated
with excellent long‐term outcomes.1 However, a large proportion of
patients develop pulmonary valve regurgitation (PR) after surgery,
which can lead to right ventricular (RV) dilatation, symptoms of RV
failure, and malignant arrhythmias, including sudden cardiac death.2,3
The QRS duration is a simple marker for predicting cardiac mortality
in several clinical conditions including post‐TOF repair with RV
failure. Intraventricular conduction delay results in abnormal elec-
trical depolarization of the heart and mechanical ventricular dys-
synchrony, which can predispose to malignant arrhythmias. QRS
duration may increase by an average of 2 msec/year in TOF patients
with secondary PR3 and a QRS interval >180msec has been
reported to be predictive for sudden cardiac death in this
population.3–5
Pulmonary valve replacement (PVR) is recommended to improve
symptoms of RV failure and reduce RV dilatation.6–8 It has also been
suggested that PVR may prevent or reverse QRS complex pro-
longation, by means of preventing volume and pressure overload
allowing mechanical re‐synchronization.9 However, data to support
the last hypothesis are scarce and conflicting.9–11 It has been sug-
gested that marked preoperative QRS prolongation and RV dilata-
tion can prevent QRS stabilization or reversal of prolongation
following PVR. In the present study we aimed to investigate the
relationship between preoperative QRS duration and RV volume, as
assessed using cardiac magnetic resonance imaging (cMRI), and
changes in QRS duration post‐PVR in patients with repaired TOF.
2 | METHOD
The study complies with the Declaration of Helsinki. The present
analysis was approved by the audit board at the University Hospital
of Bristol. As this analysis came under clinical audit/quality of care
assessment and all data were anonymized following the governance
criteria of the NHS, the IRB agreed informed consent was not
required.
2.1 | Patient and public involvement
This study was done without patient and public involvement.
2.2 | Primary and secondary endpoints
The primary endpoint of the present analysis was to describe long‐
term changes in QRS duration following PVR in relationship to pre-
operative QRS duration. As secondary endpoint, we looked at the
relationship between RV volumes and long‐term changes in QRS
duration, in a subset of patients with information on preoperative RV
volumes assessed by cardiac MRI.
2.3 | Data source
This is a single‐center cohort study conducted at the Bristol Heart
Institute looking at repaired TOF patients undergoing their first
surgical PVR. Data were retrospectively collected from medical re-
cords and the cardiac MRI database. A total of 223 TOF patients
underwent first time PVR between 1995 and 2019 in our Institution.
The main indication for the first PVR intervention was symptomatic
PR (exercise intolerance not explained by extracardiac causes, signs,
and symptoms of heart failure or syncope attributable to arrhythmia)
and/or severe right ventricle dilatation (RVEDV >150ml/m2).
Information on preoperative QRS was not available for 81 patients
who were excluded from the main analysis. Information on pre-
operative RV volumes from cMRI examination was available for 83
patients and this subgroup was used to investigate the predicted
value of RV volume on postoperative QRS duration.
TABLE 1 Characteristics of patients stratified by preoperative
QRS duration and in the overall sample







Mean (SD) 23.9 (13.0) 29.5 (12.4) 25.1 (13.1)
Sex
Men 57 (51.4%) 4 (12.9%) 61 (43.0%)
Women 54 (48.6%) 27 (87.1%) 81 (57.0%)
Chromosomal abnormality
No 99 (89.2%) 27 (87.1%) 126 (88.7%)
Yes 12 (10.8%) 4 (12.9%) 16 (11.3%)
Smoking
No 91 (82.0%) 24 (77.4%) 115 (81.0%)
Yes 20 (18.0%) 7 (22.6%) 27 (19.0%)
BSA
Mean (SD) 1.61 (0.387) 1.75 (0.308) 1.64 (0.374)
Age at first repair
Mean (SD) 3.34 (3.38) 5.27 (6.18) 3.76 (4.21)
Preop NYHA Class
1 31 (27.9%) 16 (51.6%) 47 (33.1%)
2 67 (60.4%) 14 (45.2%) 81 (57.0%)
3 13 (11.7%) 1 (3.2%) 14 (9.9%)
Preop QRS (msec)
Mean (SD) 138 (22.1) 175 (7.28) 146 (25.1)
RBBB
No 21 (18.9%) 0 (0%) 21 (14.8%)
Yes 90 (81.1%) 31 (100%) 121 (85.2%)
History of VT
No 107 (96.4%) 27 (87.1%) 134 (94.4%)
Yes 4 (3.6%) 4 (12.9%) 8 (5.6%)
Abbreviations: BSA, body surface area; PVR, pulmonary valve
replacement; RBBB, right bundle branch block; VT, ventricular
tachycardia.
2 | COCOMELLO ET AL.
Information regarding QRS duration was extracted from cardi-
ology clinical letters in the medical records. cMRI data was used as it
is considered the gold standard for quantification of RV volumes and
systolic function because of its accuracy and reproducibility.12,13
Right Ventricular volumes were indexed for body surface area.14,15
We also reported the incidence of ventricular tachycardia (VT) before
surgery defined as documented episode of spontaneous sustained VT
(e.g., cardiac arrest); electrophysiology study with inducible VT and/or
implantable cardioverter‐defibrillator (ICD) implantation for ven-
tricular arrhythmias.11
2.4 | Statistical analysis
Data are presented as median (interquartile [IQR]), mean ± standard
deviation, or as a percentage (number) where appropriate. The
overall impact of surgery on QRS duration was assessed by means of
linear mixed model using pre‐ versus postsurgery as fixed‐term, time
to evaluation as random slope, and patient‐identifiable variable as a
random intercept. To investigate the impact of preoperative QRS
duration and RV volumes, marked QRS prolongation and marked RV
volumes were defined as equal or higher than the 75th percentile of
the variable distribution. Based on this definition, a preoperative QRS
duration ≥160msec was considered marked QRS prolongation, an
indexed end‐diastolic RV volume ≥166ml/m2 and an end‐systolic RV
volume ≥89ml/m2 were considered indexes of marked RV dilatation.
Linear mixed model using time from surgery as fixed‐term and
individual patient as random effect was used to investigate
whether QRS increased (time b‐coefficient > 0), decreased (time
b‐coefficient < 0), or remained unchanged (time b‐coefficient non-
significant) following PVR. The analysis was then stratified according
to preoperative QRS duration and RV volume cut‐offs identified. For
F IGURE 1 Graphical presentation of linear mixed model showing QRS changes over time before and after surgery. Blue line represents the
overall changes with its 95% confidence interval, the red lines represent individual changes (long x axis: years from PVR). PVR, pulmonary
valve replacement
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each analysis, nonlinearity was checked by testing as 3‐knots spline
term based on Akaike information criterion (AIC) and χ2. The trend in
QRS duration across different subgroups was graphically presented
as linear regression. R and lme4 and ggplot2 packages were used for
statistical analysis.
3 | RESULTS
Patients characteristics overview in the overall sample and strati-
fied by baseline QRS duration (<160msec and >160msec) is pre-
sented in Table 1. Patients with baseline QRS duration >160 were
older at the time of PVR and were more likely to be older at the
time of the first repair. Moreover, they were more likely to have
experienced VT before surgery. The mean baseline QRS duration in
the overall sample was 146 (±25.1) msec. In patients with baseline
QRS < 160msec and >160msec was 138 ( ±22.1) and 175 (±7.28)
respectively.
3.1 | Relationship between preoperative and
postoperative QRS duration
Mean follow‐up time to postoperative QRS duration assessment was
3 years (range 1 month, 19 years). Mean QRS duration within the first
year from surgery was 142 ± 23msec. After the first year, mean QRS
duration was 146 ± 25msec. The early reduction in QRS duration soon
after surgery was minimal but evident (−2.98msec ± 1.11msec;
p < .01; Figure 1). However, we found a steady significant increase in
QRS duration of 0.42 msec ± 0.19 every year (p = .03) afterward
F IGURE 2 Graphical presentation of linear mixed model showing QRS changes after surgery in the overall population. Blue line represents
the overall changes with its 95% confidence interval (long x axis: years from PVR). PVR, pulmonary valve replacement
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(Figure 2). When the analysis was stratified based on preoperative
QRS duration, the QRS tended to increase over time in subjects with
baseline QRS duration >160 msec (p = .01), with a rate of increase of
0.87 msec ± 0.33 per year; (Figure 3). However, there was no sig-
nificant increase in the QRS duration in those with a baseline QRS
duration <160 msec (rate of increase of 0.34msec ± 0.24; p = .16)
(Figure 4).
3.2 | Relationship between preoperative RV
volumes and changes in QRS duration
Preoperative cMRI RV volumes were available in a subset of
83 patients. cMRI RV volumes in the overall sample and stratified by
QRS duration are reported in Table 2. Patients characteristics stra-
tified by baseline RV volumes are reported in Table S1. We found
F IGURE 3 Graphical presentation of
linear mixed model showing QRS changes
after surgery in patients with preoperative
QRS ≥ 160msec. Blue line represents the
overall changes with its 95% confidence
interval (long x axis: years from PVR). PVR,
pulmonary valve replacement
F IGURE 4 Graphical presentation of
linear mixed model showing QRS changes
after surgery in patients with preoperative
QRS < 160msec. Blue line represents the
overall changes with its 95% confidence
interval (long x axis: years from PVR). PVR,
pulmonary valve replacement
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TABLE 2 Preoperative MRI volumes
in patients with information from baseline
cardiac MRI available (overall and








Mean (SD) 48.2 (8.15) 47.6 (5.38) 48.1 (7.76)
RV end‐diastolic volume (mml/m2)
Mean (SD) 145 (30.6) 175 (31.6) 150 (32.5)
RV end‐systolic volume (mml/m2)
Mean (SD) 74.8 (19.0) 94.3 (16.8) 77.9 (19.9)
RV stroke volume (mml)
Mean (SD) 70.5 (18.8) 86.5 (14.7) 73.1 (19.0)
PV regurgitant fraction (%)
Mean (SD) 39.6 (11.6) 40.3 (11.5) 39.7 (11.6)
Abbreviations: PV, pulmonary valve; RV, right ventricle.
F IGURE 5 Graphical presentation of linear mixed model showing QRS changes after surgery in patients with preoperative right ventricular
end‐diastolic volume index (RVEDVi) ≥ 166ml/m2. Blue line represents the overall changes with its 95% confidence interval (long x axis:
years from PVR). PVR, pulmonary valve replacement
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that QRS duration continued to increase postoperatively in patients
with a preoperative RVEDV ≥ 166ml/m2 (2.0 msec ± 0.37 per year;
p < .01, Figure 5), but not in those with RVEDV < 166ml/m2
(0.26 ± 0.33; p = .14, Figure 6). Furthermore, postoperative QRS
duration tended to increase in subjects with large baseline RVESV
(≥89ml/m2) (1.25msec ± 0.43 per year; p = .01, Figure 7), but not in
those with smaller RVESV (<89ml/m2 (0.32 ± 0.36; p = .37, Figure 8).
4 | DISCUSSION
The main finding of the present study was that there was no decrease
in postoperative QRS duration in TOF‐repair patients undergoing sub-
sequent PVR. The subsequent trajectory in the following years was
influenced by preoperative QRS duration and RV volumes. In particular,
patients with baseline QRS duration>160 msec or markedly dilated RV
volumes (RVEDV ≥ 166ml/m2 and RVESV ≥ 89ml/m2) demonstrated a
slow but steady increase in postoperative QRS duration despite surgical
intervention. In patients with shorter preoperative QRS duration and
smaller RV volumes, the QRS duration remained unchanged.
While the association between preoperative and postoperative
QRS duration has previously been reported, to the best of our
knowledge this is the first study that demonstrates a positive cor-
relation between preoperative RV volume and duration of QRS
postoperatively. This information can be used to further inform on
optimal timing to PVR in TOF repaired patients with PR.
The increase in RV volumes is determined by a dynamic com-
ponent (i.e. volume overload) and an anatomic component
F IGURE 6 Graphical presentation of linear mixed model showing QRS changes after surgery in patients with preoperative right ventricular
end‐diastolic volume index (RVEDVi) < 166ml/m2. Blue line represents the overall changes with its 95% confidence interval (long x axis:
years from PVR). PVR, pulmonary valve replacement
COCOMELLO ET AL. | 7
(hypertrophy and fibrosis). Even though the RV may have a degree of
irreversible fibrosis and hypertrophy at the time of surgery, its vo-
lume will still decrease after PVR because of volume overload cor-
rection. However, fibrosis leads to irreversible anatomical damage to
the intraventricular conduction system.16 Once irreversible fibrosis
is established, the electrical changes tend to persist and progress
independent of postoperative changes in RV volume. This hypothesis
represents the basis of the apparent mismatch between RV volume
reduction in patients who do not show any improvement in QRS
duration following PVR.17 This hypothesis was confirmed by the
present findings.
Whether the duration of QRS decreases after PVR remains
controversial. Our series included patients who underwent sur-
gery at an earlier stage where RV volumes were not severely
affected but also patients who underwent surgery at an advanced
stage with markedly dilated RV volumes and prolonged QRS, thus
explaining the variability in QRS duration amongst our patients.
Nevertheless, we found that regardless of the baseline char-
acteristics, there were minimal changes in QRS duration after
surgery. Any changes were subject to different trajectories
according to baseline QRS. Our results are supported by a pre-
vious report from Oosterhof et al. showing that QRS duration
decreased initially after surgery, but then slowly increased by
1.09 msec/years.18 Contrarily, Therrien et al.9 found no significant
changes in QRS duration after surgery while other studies have
reported a reduction in QRS duration. However, these studies had
small sample sizes and limited follow‐up.10,19,20 A possible ex-
planation of the discordant findings by the different groups may
F IGURE 7 Graphical presentation of linear mixed model showing QRS changes after surgery in patients with preoperative right ventricular
end‐systolic volume index (RVESVi) ≥ 89ml/m2. Blue line represents the overall changes with its 95% confidence interval (long x axis: years
from PVR). PVR, pulmonary valve replacement
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reside in the variability in the duration of follow‐up between the
series. We propose that those studies with a shorter follow‐up are
more likely to reflect a small initial reduction in the QRS duration,
which is later neutralized by a progressive increase in QRS dura-
tion over an extended follow‐up. Moreover, some of the previous
studies did not account for longitudinal data which takes into
consideration variation within the same subject.
It is well established that prolonged QRS duration can ulti-
mately result in malignant arrhythmias and sudden death.
Gatzoulis et al.3 showed that patients with a QRS > 180 ms have
a significant higher risk of developing sustained ventricular
arrhythmias and sudden cardiac death during a 10‐year follow‐up.
Other studies confirmed a direct relation between QRS duration
and late arrhythmia presentation.21,22 Ventricular tachycardias
and sudden cardiac death in TOF patients are solely determined
by RV dilatation secondary to PR and therefore a timely correc-
tion of the valvular disease can dramatically improve clinical
outcomes in these patients.23 The optimal timing to perform the
PVR remains controversial: when the surgery is performed later in
life many patients experience irreversible damage to the RV, but,
early surgery can lead to multiple re‐operations over the years,
which also increase global morbidity. However, in recent years,
the impact of multiple surgeries has been mitigated by the novel
techniques of percutaneous implantation of pulmonary valves.
Therefore early surgery should not be denied solely on the basis of
the risk of future reintervention. Indeed, a recent study from
Romeo et al.24 found that a longer period between repair and PVR
is associated with the progression of QRS duration after PVR, and
F IGURE 8 Graphical presentation of linear mixed model showing QRS changes after surgery in patients with preoperative right ventricular
end‐systolic volume index (RVESVi) < 89ml/m2. Blue line represents the overall change with its 95% confidence interval. (long x axis: years from
PVR). PVR, pulmonary valve replacement
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seems to support early intervention. Our data support this finding
that it is crucial to undertake PVR before the prolongation of QRS
becomes irreversible.
5 | LIMITATIONS
The present study has limitations similar to any retrospective study.
QRS duration information was obtained by clinical entry and letter
from different clinicians over a long period of time and interobserver
variability was not accounted for in the model. Secondly, the study
sample was largely underpowered to investigate the effect of QRS
prolongation on clinical outcomes (i.e., recurrence of VT) and
therefore we can only speculate on long‐term clinical consequences
of prolonged QRS duration. Finally, the study population was en-
rolled for a long period of time and changes in patient management
may have influenced the final results.
6 | CONCLUSION
The present analysis found that after PVR in post‐TOF repair, in
subjects with shorter QRS and smaller RV volumes, QRS duration
remained unchanged after surgery. However, in those with pro-
longed QRS and dilated RV volumes, QRS tended to slowly but
steadily increase after surgery. These findings provide guidance for
clinicians on surveillance for patients with repaired TOF and PR. The
QRS duration is a very practical and inexpensive variable to monitor,
especially in primary care, and it can be used as an indication for
further investigation and escalation of treatment. The present ana-
lysis supports the hypothesis of superior outcomes following the
early intervention, that is, before QRS duration and RV volumes
reach threshold values for nonreversibility. In particular, our analysis
suggested that regardless of the presence of symptoms, patients
with preoperative QRS approaching 160msec or those with
RVEDV ≥ 166ml/m2 or RVESV ≥ 89ml/m2 should be considered for
intervention. Our results will need to be validated in other series.
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